In TDLNs and tumor tissue, the combination therapy of Fn-OMV and oHSV resulted in the most significant reduction in the number of regulatory T cells (Tregs) compared to the control group, Fn-OMV alone, or oHSV alone (Fig. 6i, j and Supplementary Fig. 9). The gene discussed is FN1; the disease is neoplasm.